Oliver G.
Treatment Name:
Single Center, Open Label Study to Evaluate the Safety of Hemoglobin-based Oxygen Carrier-201 (HBOC-201) with Carbogen Breathing During Irradiation for newly diagnosed patients with glioblastoma multiforme
Phase: Phase 1
Treatment ID#: 631
Age Group: Adults Only
Min Karnofsky Score: 60: Requires occasional assistance but is able to care for most of own needs
Conditions: Prior Surgery is Allowed
Prior Radiation is Not Allowed
Prior Chemotherapy is Not Allowed
Last Updated: 05/11/2001
Tumor Types: Glioblastoma Multiforme
Comments: radiation therapy must be done at University of California, SF HBOC (hemoglobin-based oxygen carrier) three times a week daily breathing of carbogen (95% oxygen/5% carbon dioxide) to increase the oxygen to the tumor
Michael Prados MD
U. Of California At San Francisco
400 Parnassus Avenue, Rm A808
San Francisco, CA 94143- USA
Phone: (415)353-2966
Fax: (415)353-2167
E-mail: pradosm@neurosurg.ucsf.edu
Website: cc.ucsf.edu nabtc.org